Back
  1. Home
  2. Profile of Sabine Olivier (ULiège)
Profil

Olivier Sabine

Main Referenced Co-authors
Bours, Vincent  (7)
Merville, Marie-Paule  (5)
Malaise, Michel  (4)
Chariot, Alain  (3)
Artesi, Maria  (2)
Main Referenced Keywords
NF kappa B (2); Animals (1); Anti-Inflammatory Agents, Non-Steroidal/pharmacology/therapeutic use (1); Antineoplastic Agents/pharmacology/therapeutic use (1); Apoptosis/drug effects/physiology (1);
Main Referenced Unit & Research Centers
Giga-Signal Transduction - ULiège [BE] (2)
Main Referenced Disciplines
Biochemistry, biophysics & molecular biology (3)
Endocrinology, metabolism & nutrition (2)
Pharmacy, pharmacology & toxicology (2)
Genetics & genetic processes (2)
Laboratory medicine & medical technology (1)

Publications (total 8)

The most downloaded
985 downloads
Olivier, S., Robe, P., & Bours, V. (2006). Can NF-kappaB be a target for novel and efficient anti-cancer agents? Biochemical Pharmacology, 72 (9), 1054-1068. doi:10.1016/j.bcp.2006.07.023 https://hdl.handle.net/2268/83954

The most cited

118 citations (Scopus®)

Olivier, S., Robe, P., & Bours, V. (2006). Can NF-kappaB be a target for novel and efficient anti-cancer agents? Biochemical Pharmacology, 72 (9), 1054-1068. doi:10.1016/j.bcp.2006.07.023 https://hdl.handle.net/2268/67810

Grentzinger, V., Artesi, M., Gonon Rodrigues Palmeira, L., Dideberg, V., Olivier, S., Bours, V., & Durkin, K. (24 April 2024). Hidden in Plain Sight: Homologous Recombination masks Filaggrin Alleles of Potential Clinical Significance [Poster presentation]. byteMAL 2024, Maastricht, Netherlands.

Grentzinger, V., Durkin, K. W., Gonon Rodrigues Palmeira, L., Artesi, M., Olivier, S., & Bours, V. (24 November 2023). Identification of novel haplotypes within the challenging medically relevant FLG gene [Poster presentation]. SFMBBM PhD Day, Liège, Belgium.

Keutgens, A., Zhang-Shao, X., Shostak, K., Robert, I., Olivier, S., Vanderplasschen, A., Chapelle, J.-P., Viatour, P., Merville, M.-P., Bex, F., Gothot, A., & Chariot, A. (2010). BCL-3 degradation involves its polyubiquitination through a FBW7-independent pathway and its binding to the proteasome subunit PSMB1. Journal of Biological Chemistry, 285 (33), 25831–25840. doi:10.1074/jbc.M110.112128
Peer Reviewed verified by ORBi

Olivier, S., Close, P., Castermans, E., de Leval, L., Tabruyn, S., Chariot, A., Malaise, M., Merville, M.-P., Bours, V., & Franchimont, N. (May 2006). Raloxifene-induced myeloma cell apoptosis: a study of nuclear factor-kappaB inhibition and gene expression signature. Molecular Pharmacology, 69 (5), 1615-1623. doi:10.1124/mol.105.020479
Peer Reviewed verified by ORBi

Olivier, S., Robe, P., & Bours, V. (2006). Can NF-kappaB be a target for novel and efficient anti-cancer agents? Biochemical Pharmacology, 72 (9), 1054-1068. doi:10.1016/j.bcp.2006.07.023
Peer Reviewed verified by ORBi

Olivier, S., Close, P., Castermans, E., de Leval, L., Tabruyn, S., Chariot, A., Malaise, M., Merville, M.-P., Bours, V., & Franchimont, N. (September 2005). SERMs-induced myeloma cell apoptosis: A study of NF-kappa B inhibition and gene expression signature. Journal of Bone and Mineral Research, 20 (9, Suppl. 1), 213.

Olivier, S., Fillet, M., Malaise, M., Piette, J., Bours, V., Merville, M.-P., & Franchimont, N. (2005). Sodium nitroprusside-induced osteoblast apoptosis is mediated by long chain ceramide and is decreased by raloxifene. Biochemical Pharmacology, 69 (6), 891-901. doi:10.1016/j.bcp.2004.11.030
Peer Reviewed verified by ORBi

Olivier, S., Fillet, M., Malaise, M., Piette, J., Bours, V., Merville, M.-P., & Franchimont, N. (September 2003). Raloxifene protects Osteoblasts from apoptosis induced by sodium nitroprusside: Potential involvement of ceramide. Journal of Bone and Mineral Research, 18 (Suppl. 2), 136.

Contact ORBi